Back

Predicting heart failure in cancer survivors: use of polygenic risk vs clinical score

30 August 2024 (10:10 - 10:20)
Organised by: Logo
Congress Presentation Part of: Get out your crystal ball: predicting heart failure events using models Prevention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Cheng Hwee Soh

Baker Heart and Diabetes Institute, Melbourne (Australia)

4 More presentations in this session

Presentation thumbnail
Development and validation of a predicting model for risk of rehospitalization within 30 days in heart failure patients with preserved ejection fraction
Professor Y. Zhu (Xiangtan, CN)
Abstract Slides Video
Presentation thumbnail
Machine learning to improve the performance of natriuretic peptides across age groups for the diagnosis of acute heart failure
Mr D. Perez Vicencio (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Enhancing the selection of heart failure patients for invasive procedures: how machine learning can predict the diagnostic yield of endomyocardial biopsy
Doctor C. Basile (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
High prevalence of cardiotropic viruses in endomyocardial biopsies from patients with inflammatory cardiomyopathy demonstrated by a novel targeted NGS approach
Doctor C. Baumeier (Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Get out your crystal ball: predicting heart failure events using models
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 10:10 CET
You may be interested in
thumbnail
Congress Presentation
Comparison of cardiovascular disease risk assessment tools for heart failure prediction among cancer patients
30 August 2024
thumbnail
Congress Presentation
Complex genetics in heart failure and cardiomyopathies.
27 August 2022
thumbnail
Congress Presentation
Polygenic risk-based prediction of AF in cancer patients: an analysis from UK biobank
30 March 2025
thumbnail
Congress Session
Heart failure: prediction and prognosis
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources